Gross G J, Pieper G M
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.
Pharmacology. 1989;38(6):341-51. doi: 10.1159/000138557.
The effects of nicorandil, indomethacin and nicorandil + indomethacin on subendocardial segment shortening (%SS), regional myocardial blood flow and coronary venous thromboxane (TxA2) and prostacyclin (PGI2) levels were compared to those of a saline-treated group in anesthetized dogs subjected to a 15-min coronary artery occlusion and 3 h of reperfusion. During reperfusion, nicorandil markedly improved %SS in the ischemic-reperfused region compared to saline- and indomethacin-treated dogs. Indomethacin did not antagonize the beneficial effects of nicorandil. These results suggest that the beneficial actions of nicorandil in this model are not the result of an increase in PGI2 or decrease in TxA2 synthesis.
在麻醉犬身上进行15分钟冠状动脉闭塞和3小时再灌注后,将尼可地尔、吲哚美辛以及尼可地尔+吲哚美辛对心内膜下节段缩短率(%SS)、局部心肌血流量、冠状静脉血栓素(TxA2)和前列环素(PGI2)水平的影响,与生理盐水治疗组进行比较。在再灌注期间,与生理盐水和吲哚美辛治疗的犬相比,尼可地尔显著改善了缺血再灌注区域的%SS。吲哚美辛并未拮抗尼可地尔的有益作用。这些结果表明,在该模型中,尼可地尔的有益作用并非PGI2增加或TxA2合成减少的结果。